Hepatitis C: The Basics

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
Hepatitis C is a viral disease spread via blood that affects liver function and can lead to cirrhosis, cancer, and death. Risk factors include receiving blood transfusions or organ transplants before 1992, sharing intravenous drug needles or cocaine straws, engaging in rough sex, and receiving tattoos or piercings from unsterilized equipment. Unlike hepatitis A and B, there is no vaccine for hepatitis C. It can be cured through treatment, however, so it is important for those with risk factors to learn whether they have it.
 
Check out this video to learn more:

Related Articles
A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.
The drugmaker will no longer pursue FDA approval of its dual daclatasvir and asunaprevir treatment for patients with hepatitis C virus genotype 1b.
Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C.
A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone.
Latest Issues
$auto_registration$